Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim

全碳水化合物疫苗结构及其在检测糖蛋白中的应用

基本信息

  • 批准号:
    8327138
  • 负责人:
  • 金额:
    $ 0.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2012-08-25
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The principal goal of this research program is to develop practical synthetic approaches for the modification of a unique capsular zwitterionic polysaccharide (ZPS), PS A1, and conjugate tumor-associated carbohydrate antigens (TACAs) to develop entirely carbohydrate vaccine constructs. PS A1 is a structurally well- characterized polysaccharide containing a repeating tetrasaccharide core isolated from the capsular polysaccharide complex (CPC) of the anaerobe Bacterioides fragilis NCTC 9343. It was determined that PS A1 could coax an immune system to elicit cellular and humoral immune functions via T- and B-cell involvement that influenced helper and memorial response events - a paradigm shifting discovery. What is not entirely clear is the immunogenicity of entirely carbohydrate-based constructs as an alternative approach to glycoprotein conjugates for tumor vaccine development. This research program, therefore, aims to study and assess the innovative vaccine constructs using three specific aims: 1) To develop efficient conjugation methods for the construction of structurally well-defined TACA-PS A1 conjugate vaccines, 2) To study the immunological properties of TACA-PS A1 conjugates in mice and evaluate the specificity and cytotoxicity of TACA-PS A1- raised Abs to human cancer cell lines, and 3) To evaluate, in vivo, the efficacy of TACA-PS A1-invoked immunity to treat tumors. Anti-sera, obtained from murine immunizations will be used to determine total antibody (Ab) titers and Ab isotypes by ELISA, relaying information about immunity. Furthermore, ELISA will be used to determine Ab specificity against conjugated TACAs. Flow cytometry will be used to validate Ab specificity with human cancer cell lines. Complement-mediated cell killing (cytotoxicity) analysis using human tumor cell lines, will reveal Ab function. Finally, assessing and evaluating the efficacy of select TACA-PS A1 constructs to treat cancer will be demonstrated through in vivo experiments utilizing murine models grafted with the TA3/Ha murine breast carcinoma. The broader impact of the proposed research aims to demonstrate how entirely carbohydrate-based vaccines elicit cellular and humoral responses in the immune system. This research program will contribute to improved methodologies for the field of glycoconjugation chemistry, a better understanding of the role of PS A1 as an immunogen in eliciting immune responses, and assessment and evaluation of cancer specific constructs that are rationally designed. This project will, therefore, have an important impact on cancer treatment by providing a novel carbohydrate-based agent for preventive and therapeutic medicine and increase our understanding of glycoimmunology. We also expect this program to be broadly applicable to other areas of vaccine research.
描述(由申请方提供):本研究项目的主要目标是开发用于修饰独特的荚膜两性离子多糖(ZPS)、PS A1和结合肿瘤相关碳水化合物抗原(TACA)的实用合成方法,以开发完全碳水化合物疫苗构建体。PS A1是一种结构上充分表征的多糖,含有从厌氧菌脆弱拟杆菌NCTC 9343的荚膜多糖复合物(CPC)分离的重复四糖核心。已确定PS A1可以诱导免疫系统通过影响辅助和记忆反应事件的T细胞和B细胞参与来引发细胞和体液免疫功能-一个范式转变的发现。不完全清楚的是完全基于碳水化合物的构建体作为糖蛋白缀合物用于肿瘤疫苗开发的替代方法的免疫原性。因此,本研究计划旨在研究和评估创新疫苗构建体,具有三个特定目标:1)开发用于构建结构明确的TACA-PS A1缀合物疫苗的有效缀合方法,2)研究TACA-PS A1缀合物在小鼠中的免疫学特性,并评估TACA-PS A1- raised Ab对人癌细胞系的特异性和细胞毒性,和3)在体内评价TACA-PS A1引发的免疫治疗肿瘤的功效。将使用从鼠免疫接种中获得的抗血清通过ELISA测定总抗体(Ab)滴度和Ab同种型,传递免疫力相关信息。此外,ELISA将用于确定针对结合TACA的Ab特异性。流式细胞术将用于验证Ab对人癌细胞系的特异性。使用人肿瘤细胞系的补体介导的细胞杀伤(细胞毒性)分析将揭示Ab功能。最后,通过利用移植有TA 3/Ha鼠乳腺癌的鼠模型的体内实验来证明评估和评价选择的TACA-PS A1构建体治疗癌症的功效。拟议研究的更广泛影响旨在证明完全基于碳水化合物的疫苗如何在免疫系统中引起细胞和体液反应。该研究计划将有助于改进糖缀合化学领域的方法,更好地理解PS A1作为免疫原在引发免疫应答中的作用,以及评估和评价合理设计的癌症特异性构建体。因此,该项目将对癌症治疗产生重要影响,为预防和治疗药物提供一种新的基于碳水化合物的药物,并增加我们对糖免疫学的理解。我们还希望该计划能够广泛适用于疫苗研究的其他领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter R Andreana其他文献

Peter R Andreana的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter R Andreana', 18)}}的其他基金

2023 Carbohydrates Gordon Research Conference and Gordon Research Seminar
2023年碳水化合物戈登研究会议暨戈登研究研讨会
  • 批准号:
    10682774
  • 财政年份:
    2023
  • 资助金额:
    $ 0.21万
  • 项目类别:
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
全碳水化合物疫苗结构及其在检测糖蛋白中的应用
  • 批准号:
    8529201
  • 财政年份:
    2011
  • 资助金额:
    $ 0.21万
  • 项目类别:
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
全碳水化合物疫苗构建体及其在检测糖蛋白中的应用
  • 批准号:
    8730098
  • 财政年份:
    2011
  • 资助金额:
    $ 0.21万
  • 项目类别:
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
全碳水化合物疫苗结构及其在检测糖蛋白中的应用
  • 批准号:
    8619236
  • 财政年份:
    2011
  • 资助金额:
    $ 0.21万
  • 项目类别:
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
全碳水化合物疫苗结构及其在检测糖蛋白中的应用
  • 批准号:
    8025169
  • 财政年份:
    2011
  • 资助金额:
    $ 0.21万
  • 项目类别:
Chemical Development of Fluorescent Labeling Tags for DNA Damaged Sites
DNA 损伤位点荧光标记标签的化学开发
  • 批准号:
    8101250
  • 财政年份:
    2010
  • 资助金额:
    $ 0.21万
  • 项目类别:
Chemical Development of Fluorescent Labeling Tags for DNA Damaged Sites
DNA 损伤位点荧光标记标签的化学开发
  • 批准号:
    8009709
  • 财政年份:
    2010
  • 资助金额:
    $ 0.21万
  • 项目类别:
Asymmetric Ugi for a Diversity-Oriented Pathway
面向多样性的途径的不对称 Ugi
  • 批准号:
    6739132
  • 财政年份:
    2004
  • 资助金额:
    $ 0.21万
  • 项目类别:
Asymmetric Ugi for a Diversity-Oriented Pathway
面向多样性的途径的不对称 Ugi
  • 批准号:
    6881220
  • 财政年份:
    2004
  • 资助金额:
    $ 0.21万
  • 项目类别:

相似海外基金

Identification and isolation of anaerobic bacteria that degrade bacterial cell wall
降解细菌细胞壁的厌氧菌的鉴定与分离
  • 批准号:
    22H02487
  • 财政年份:
    2022
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Enzymology of cofactor and amino acid metabolism in anaerobic bacteria
厌氧菌辅助因子和氨基酸代谢的酶学
  • 批准号:
    RGPIN-2022-03200
  • 财政年份:
    2022
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Discovery Grants Program - Individual
High-throughput isolation of anaerobic bacteria
厌氧菌的高通量分离
  • 批准号:
    572711-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 0.21万
  • 项目类别:
    University Undergraduate Student Research Awards
Elucidating the mechanisms of O2-sensitivity of anaerobic bacteria Bifidobacterium.
阐明厌氧菌双歧杆菌的 O2 敏感性机制。
  • 批准号:
    22K07058
  • 财政年份:
    2022
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Automatic and accurate identification of aerobic bacteria, anaerobic bacteria, yeasts, and fungi in clinical samples derived from animals and from feed for pets
自动、准确地鉴定来自动物和宠物饲料的临床样品中的需氧细菌、厌氧细菌、酵母菌和真菌
  • 批准号:
    10440741
  • 财政年份:
    2021
  • 资助金额:
    $ 0.21万
  • 项目类别:
Regulation of virulence in fungi under coculture condition with anaerobic bacteria
厌氧菌共培养条件下真菌毒力的调节
  • 批准号:
    21K07009
  • 财政年份:
    2021
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Polymicrobial interactions between commensal obligate anaerobic bacteria and cystic fibrosis pathogen P. aeruginosa
共生专性厌氧菌与囊性纤维化病原体铜绿假单胞菌之间的多种微生物相互作用
  • 批准号:
    10275319
  • 财政年份:
    2021
  • 资助金额:
    $ 0.21万
  • 项目类别:
Platform for the automated isolation and characterization of anaerobic bacteria
厌氧菌自动分离和表征平台
  • 批准号:
    445552570
  • 财政年份:
    2020
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Major Research Instrumentation
Development of therapy for triple negative breast cancer using anaerobic bacteria
利用厌氧菌开发三阴性乳腺癌疗法
  • 批准号:
    19K16452
  • 财政年份:
    2019
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of gene engineering method for anaerobic bacteria for efficient bio-hydrogen production
开发厌氧菌高效生物制氢的基因工程方法
  • 批准号:
    18K11708
  • 财政年份:
    2018
  • 资助金额:
    $ 0.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了